Abstract

Aims/hypothesisThis study aimed to examine the metabolic health of young apparently healthy non-obese adults to better understand mechanisms of hyperinsulinaemia.MethodsNon-obese (BMI < 30 kg/m2) adults aged 18–35 years (N = 254) underwent a stable isotope-labelled OGTT. Insulin sensitivity, glucose effectiveness and beta cell function were determined using oral minimal models. Individuals were stratified into quartiles based on their insulin response during the OGTT, with quartile 1 having the lowest and quartile 4 the highest responses.ResultsThirteen per cent of individuals had impaired fasting glucose (IFG; n = 14) or impaired glucose tolerance (IGT; n = 19), allowing comparisons across the continuum of insulin responses within the spectrum of normoglycaemia and prediabetes. BMI (~24 kg/m2) was similar across insulin quartiles and in those with IFG and IGT. Despite similar glycaemic excursions, fasting insulin, triacylglycerols and cholesterol were elevated in quartile 4. Insulin sensitivity was lowest in quartile 4, and accompanied by increased insulin secretion and reduced insulin clearance. Individuals with IFG had similar insulin sensitivity and beta cell function to those in quartiles 2 and 3, but were more insulin sensitive than individuals in quartile 4. While individuals with IGT had a similar degree of insulin resistance to quartile 4, they exhibited a more severe defect in beta cell function. Plasma branched-chain amino acids were not elevated in quartile 4, IFG or IGT.Conclusions/interpretationHyperinsulinaemia within normoglycaemic young, non-obese adults manifests due to increased insulin secretion and reduced insulin clearance. Individual phenotypic characterisation revealed that the most hyperinsulinaemic were more similar to individuals with IGT than IFG, suggesting that hyperinsulinaemic individuals may be on the continuum toward IGT. Furthermore, plasma branched-chain amino acids may not be an effective biomarker in identifying hyperinsulinaemia and insulin resistance in young non-obese adults.

Highlights

  • Hyperinsulinaemia is the central component of the metabolic syndrome, and is an independent predictor of metabolic and cardiovascular disease [1,2,3,4,5,6]

  • While BMI was similar across groups, the proportion of overweight (BMI > 25 kg/m2) individuals was significantly different among groups (χ2 test p < 0.01), with a greater proportion in the impaired glucose tolerance (IGT) group

  • We aimed to develop a deeper understanding of the systemslevel mechanisms involved in obesity-independent hyperinsulinaemia

Read more

Summary

Introduction

Hyperinsulinaemia is the central component of the metabolic syndrome, and is an independent predictor of metabolic and cardiovascular disease [1,2,3,4,5,6]. Hyperinsulinaemia is viewed as a compensatory response whereby beta cells hypersecrete insulin to overcome reduced tissue insulin action to maintain normal glycaemic control. It is not clear how, in the face of normal blood glucose, beta cells sense and adjust insulin secretion to precisely compensate for tissue insulin resistance [7]. An alternative hypothesis exists whereby primary insulin hypersecretion initiates insulin resistance [8,9,10] In this scenario, hyperinsulinaemia downregulates tissue insulin action (insulin-induced insulin resistance) [8,9,10,11,12,13]. Regardless of its evolution, hyperinsulinaemia is pathological; understanding what drives hyperinsulinaemia is of high importance

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call